Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming

R.S.G. Sablerolles, W.J.R. Rietdijk, A. Goorhuis, D.F. Postma, L.G. Visser, D. Geers, K.S. Schmitz, H.M. Garcia Garrido, M.P.G. Koopmans, V.A.S.H. Dalm, N.A. Kootstra, A.L.W. Huckriede, M. Lafeber, D. van Baarle, C.H. GeurtsvanKessel, R.D. de Vries, P.H.M. van der Kuy on behalf of the SWITCH research group
doi: https://doi.org/10.1101/2021.10.18.21264979

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted October 22, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
R.S.G. Sablerolles, W.J.R. Rietdijk, A. Goorhuis, D.F. Postma, L.G. Visser, D. Geers, K.S. Schmitz, H.M. Garcia Garrido, M.P.G. Koopmans, V.A.S.H. Dalm, N.A. Kootstra, A.L.W. Huckriede, M. Lafeber, D. van Baarle, C.H. GeurtsvanKessel, R.D. de Vries, P.H.M. van der Kuy
medRxiv 2021.10.18.21264979; doi: https://doi.org/10.1101/2021.10.18.21264979
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area